Dr. Antonio Parente obtained his BSc in Chemistry and PhD in Organic Chemistry from the University of Barcelona, an MBA and further business qualifications from ESADE and IESE. He co-founded Lipotec SA, BCN-Peptides SA, Diverdrugs SL, Lipofoods SA, BCN Corp SL and Primaderm SA., where he served different manager or counselling positions. In 2000, he founded GP Pharm SA, where he currently acts as President. Dr. Parente is member of the board of the Centre for Genomic Regulation, Barcelona, and has greatly contributed to the success of the local biotechnology ecosystem through ASEBIO (Spanish Biotech Companies Association) and CataloniaBio and Health Tech.

Dr. Parente acts as a Business Consultor and/or Business Angel in 10 Biotech companies in Spain.